Skip to main content

Revision Bulletins

Revision Bulletins are published in USP–NF Online by the first of each month. Each Revision Bulletin includes a notice that provides the reason for the change and the official date. Monograph names listed before April 1, 2021 contain a combined notice and documentary standard; postings after April 1, 2021 provide separate links for the notice and for the standard content. For more information on the Revision Bulletins and the Accelerated Revision process, see USP's Guideline on the Use of Accelerated Processes for Revisions to USP–NF. Archived Revision Bulletins can be found here.

See the Publication & Comment Schedule section for specific posting and official dates.

New and Updated Revision Bulletins

  • Chlorpromazine Hydrochloride Oral Concentrate (posted 14–Jun–2021; official 15–Jun–2021) Previously published as Pending- Notice of Intent to Revise
  • (+)-1-(9-Fluoroenyl) ethyl Chloroformate Solution Reagent and Notice (posted 28–May–2021; official 01–Jun–2021)
  • Buspirone Hydrochloride Tablets Monograph and Notice (posted 28–May–2021; official 01–Jun–2021)
  • Lovastatin Tablets Monograph and Notice (posted 28–May–2021; official 01–Jun–2021)
  • Mesalamine Delayed-Release Tablets Monograph and Notice (posted 28–May–2021; official 01–Jun–2021)
  • Nitrofurantoin Capsules Monograph and Notice (posted 28–May–2021; official 01–Jun–2021)
  • Prasugrel Tablets Monograph and Notice (posted 28–May–2021; official 01–Aug–2021)

Revision Bulletins

To view Accelerated Revisions by official date, please click here.